Finance

Beta
Lists
AURA:NASDAQ
Aura Biosciences Inc
$6.84
-2.29%
(-0.16) 1D
$6.84
0.00% (0.00)
After hours
Closed: Jul 10, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AURA...
Open
$7.00
High
$7.30
Low
$6.64
Mkt. cap
707.50M
Avg. vol.
647.87K
Volume
442.81K
52-wk high
$9.54
52-wk low
$4.73
EPS
-$1.74
Beta
0.40
Shares outstanding
103.44M
No. of employees
113
Open
$7.00
High
$7.30
Low
$6.64
Mkt. cap
707.50M
Avg. vol.
647.87K
Volume
442.81K
52-wk high
$9.54
52-wk low
$4.73
EPS
-$1.74
Beta
0.40
Shares outstanding
103.44M
No. of employees
113
News stories
From sources across the web
About Aura Biosciences Inc
CEO-
Employees113
Founded2009
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Websiteaurabiosciences.com
Analyst ratings
Based on 5 analysts giving stock ratings to AURA in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for AURA in the last 3 months.
Highest
Current $6.84
$24.00 (+250.88%)
Average
$20.67 (+202.19%)
Lowest
$15.00 (+119.30%)
Analyst
Recommendation
Action
Price target
Projected
Date
Andrew Berens
Leerink Partners
Buy
Reiterated
-
-
06/02/2026
Andres Y. Maldonado
H.C. Wainwright
Buy
Maintained
$24.00
+250.9%
05/26/2026
Oliver McCammon
LifeSci Capital
Buy
Maintained
$23.00
+236.3%
05/16/2026
Phil Nadeau
TD Cowen
Buy
Maintained
-
-
05/11/2026
Jonathan Miller
Evercore ISI
Buy
Maintained
$15.00
+119.3%
04/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
22.88M
22.18M
21.90M
27.96M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.73M
5.73M
5.34M
6.91M
Operating expense
28.61M
27.91M
27.24M
34.87M
Total operating expenses
28.61M
27.91M
27.24M
34.87M
Operating income
-28.61M
-27.91M
-27.24M
-34.87M
Other non operating income
-36.00K
-13.00K
149.00K
2.00K
EBT including unusual items
-26.97M
-26.10M
-25.54M
-33.67M
EBT excluding unusual items
-26.97M
-26.10M
-25.54M
-33.67M
Income tax expense
48.00K
26.00K
15.00K
11.00K
Effective tax rate
-0.18%
-0.10%
-0.06%
-0.03%
Other operating expenses
-
-
-
-
Net income
-27.02M
-26.13M
-25.56M
-33.68M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
1.68M
1.82M
1.54M
1.19M
Interest expense
-
-
-
-
Net interest expenses
1.68M
1.82M
1.54M
1.19M
Depreciation and amortization charges
-
-
-
-
EBITDA
-28.33M
-27.63M
-26.96M
-34.59M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer